SCHEDULE 13G 0002043812 XXXXXXXX LIVE Ordinary Shares, par value $0.0009 per share 09/12/2025 0002022416 Silexion Therapeutics Corp. G1281K122 12 Abba Hillel Road Ramat-Gan L3 52522 Rule 13d-1(c) Lincoln Alternative Strategies LLC b DE 131250.00 0.00 131250.00 0.00 131250.00 N 6.18 OO Beneficial ownership percentage is based on 2,123,892 shares of the Issuer's common stock issued and outstanding as of September 12, 2025. Silexion Therapeutics Corp. 12 Abba Hillel Road, Ramat-Gan, L3, 52522 Lincoln Alternative Strategies LLC 404 Washington Ave., Suite 650, Miami Beach, FL 33139 Delaware Y 131,250 6.18% 131,250 0 131,250 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Lincoln Alternative Strategies LLC /s/ Stephen Temes 09/15/2025